| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |